External links
- The silent thief: Faculty member warns of glaucoma, shares research hopes, Indiana University
- Mount Sinai Medical Center homepage
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
Alon Harris | |
|---|---|
| Education | Indiana University |
| Occupation(s) | Clinical Scientist Professor of Ophthalmology |
| Children | Jonathan and Danielle |
| Medical career | |
| Institutions | Icahn School of Medicine at Mount Sinai Visiting Professorships Lithuanian University of Health Sciences, LithuaniaBen Gurion University Medical Center, Be’er Sheva, Israel Tel Aviv University |
| Research | Ophthalmology |
Alon Harris is an American clinical scientist, professor of ophthalmology and Professor of Artificial Intelligence and Human Health, [1] [2] educator, inventor and researcher in the field of ocular blood flow and its relationship to diseases of the eye. Harris served as the principal or co-principal investigator on more than 60 research grants, published more than 392 peer-reviewed articles, and wrote 23 books and 70 book chapters. [3] [4] As of 2021, he holds two patents. Harris sits on the board of directors and the Scientific Advisory Board of The Glaucoma Foundation [5] and is the Vice Chair of International Research and Academic Affairs, co-director of the Center for Ophthalmic Artificial Intelligence and Human Health at Mount Sinai Hospital, and Director of the Ophthalmic Vascular Diagnostic and Research Program at Icahn School of Medicine at Mount Sinai. [6]
Harris's post-doctorate training in medical science physiology was at Indiana University in 1990. He received an MS in 1985 and PhD in 1988 in human performance/physiology. Subsequently, he took positions at Indiana University School of Medicine, including the Lois Letzter Endowed Chair in Ophthalmology, [7] Professor of Ophthalmology, Professor of Cellular and Integrative Physiology, and Director, Glaucoma Research and Diagnostic Center, Department of Ophthalmology. [8] [9] He served as Director of Clinical Research at the Glick Eye Institute. [10] [11] Harris was co-chair, World Glaucoma Congress Consensus on Ocular Blood Flow, [12] and was a member of the international faculty board of the PhD program in Experimental Medicine, University of Pavia.
Harris's clinical research focus includes: ocular blood flow; [13] glaucoma; intraocular pressure and hemodynamics related to eye disorders; [14] ophthalmic risk factor assessment; structural and functional progression monitoring; non-evasive imaging of diseases such as glaucoma; brain and eye physiology; modeling for factors that increase or decrease disease susceptibilities in terms of race, gender, and conditions such as diabetes. [8] [15] [16]
In collaboration with mathematicians, Harris uses modeling and artificial intelligence applications to increase precision of diagnostics and disease management. [1]
Harris has multiyear support from the National Science Foundation, grants from the NIH, American Diabetes Association and National Eye Institute. As of 2020, he has served as co-investigator or principal investigator (PI) on more than 60 grants related to ocular vascular physiology. [17] [18] [19] [7] He was co-PI on The Thessaloniki Eye Study, reportedly ophthalmology's largest population-based study. [12]
Harris is co-inventor on an international patent application, Methods and systems for patient specific identification and assessment of ocular disease risk factors and treatment efficacy, [20]
He developed and generated data for two patents: "Treatment of Macular Edema" [21] and "Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight." [22] [23]
Harris is the founder and co-editor of Modeling and Artificial Intelligence in Ophthalmology (formerly Journal of Modeling in Ophthalmology). [24] [25] As of 2020, he is also on the board of the Journal of Ophthalmology, [26] Acta Ophthalmologica Scandinavica, [27] Journal of Glaucoma, [28] and PLOS ONE. [29]
Partial list:
Google Scholar reports that Harris's publications are cited 18,871 times, that he has an h-index of 75 and an i10-index of 280. [4]
Partial list of peer-reviewed papers:
Partial list of honors and awards:
As of 2020, memberships include:
{{cite journal}}: Cite journal requires |journal= (help)| International | |
|---|---|
| National | |
| Academics | |
| Other | |
